Ohio Cannabis Referendum: Ballot Initiatives, Campaigns & Legal Status

Executive Summary

A signature-gathering campaign for a 2026 Ohio cannabis and hemp referendum has collapsed amid allegations that organizers failed to pay petition circulators as promised, jeopardizing the initiative's path to the November ballot. Multiple petitioners reported in May 2026 that they had not received compensation for collecting voter signatures, raising questions about the campaign's financial management and viability. The referendum sought to expand Ohio's existing medical marijuana program and establish a regulated hemp market, building on the state's 2023 adult-use legalization measure. The payment controversy has stalled signature collection efforts and cast doubt on whether organizers can meet Ohio's constitutional requirement of valid signatures from at least 44 counties representing 10% of voters who cast ballots in the most recent gubernatorial election. This setback represents the latest challenge in Ohio's evolving cannabis landscape, where regulatory implementation, market access, and grassroots advocacy continue to intersect in complex ways.

Why This Matters

The failure of this referendum campaign affects Ohio's 11.8 million residents, its emerging cannabis industry valued at over $400 million annually, and the broader national trajectory of state-level cannabis reform. For Ohio patients and consumers, the referendum promised expanded access to cannabis products and clearer hemp regulations. The state's medical marijuana program, established under Ohio Rev. Code § 3796, currently serves approximately 250,000 registered patients. The proposed referendum aimed to address gaps in the existing framework, including product variety restrictions and geographic access disparities that leave rural patients traveling over 50 miles to reach dispensaries. For Ohio's cannabis operators, the measure represented potential market expansion and regulatory clarity. The state's Division of Cannabis Control oversees 130 licensed dispensaries, 25 cultivators, and 18 processors as of May 2026. Multi-state operators including Cresco Labs, Curaleaf, and Ayr Wellness have invested over $200 million in Ohio infrastructure since 2019. The referendum's provisions on hemp-derived cannabinoids would have resolved ongoing legal ambiguity affecting CBD retailers, gas stations, and convenience stores selling delta-8 THC and similar compounds. The payment controversy also matters for direct democracy itself. Ohio's citizen-initiated referendum process, governed by Article II, Section 1 of the Ohio Constitution, requires grassroots campaigns to navigate complex signature-gathering logistics. Professional petition firms typically charge $3 to $8 per signature in competitive states. When campaigns fail to compensate circulators, it undermines trust in the initiative process and makes future reform efforts more difficult to organize.

Background and History: Ohio's Cannabis Reform Journey

Ohio's path to cannabis reform has been marked by false starts, narrow defeats, and eventual voter-driven success—a decade-long evolution that provides essential context for understanding the 2026 referendum controversy.

Early Medical Marijuana Efforts (2015-2016)

Ohio voters first confronted cannabis legalization in November 2015, when Issue 3—a constitutional amendment combining medical and adult-use legalization—appeared on the ballot. The measure, backed by the ResponsibleOhio campaign, proposed creating 10 exclusive cultivation sites controlled by the initiative's investors. This monopolistic structure drew fierce opposition from reform advocates, conservative groups, and the Ohio General Assembly, which placed a competing measure (Issue 2) on the same ballot to ban monopolies in the state constitution. Issue 3 failed with 64% voting against, while Issue 2 passed with 51% support. Following Issue 3's defeat, the Ohio legislature enacted medical marijuana legislation in June 2016. House Bill 523, signed by Governor John Kasich, established a regulated medical cannabis program under Ohio Rev. Code § 3796. The law authorized licensed cultivation, processing, testing, and dispensing for 21 qualifying medical conditions including cancer, epilepsy, chronic pain, and PTSD. The program prohibited home cultivation and smoking of cannabis flower, limiting patients to vaporization, edibles, oils, and tinctures.

Program Implementation and Growing Pains (2017-2019)

Ohio's medical marijuana program faced significant implementation delays. The State Board of Pharmacy and State Medical Board spent 18 months developing regulations for dispensaries, physicians, and patients. The Department of Commerce (later reorganized into the Division of Cannabis Control) conducted competitive licensing rounds for cultivators and processors in 2017-2018, awarding 24 cultivation licenses and 18 processing licenses. The first Ohio dispensaries opened in January 2019, nearly three years after HB 523's passage. Initial patient access remained limited due to high product costs (averaging $400-500 per ounce), physician reluctance to issue recommendations, and geographic concentration of dispensaries in urban areas. By December 2019, only 15,000 patients had registered for medical cards, far below projections of 100,000-200,000 patients.

Adult-Use Legalization Campaign (2022-2023)

As Ohio's medical program matured, adult-use legalization advocates launched a new citizen-initiated statute campaign. The Coalition to Regulate Marijuana Like Alcohol, backed by cannabis industry groups and national reform organizations, filed a proposed statute in December 2022. The measure would legalize possession of up to 2.5 ounces for adults 21 and older, permit home cultivation of up to six plants per individual (12 per household), and establish a regulated retail market with a 10% excise tax. Signature gathering began in February 2023. The campaign needed 132,887 valid signatures from at least 44 of Ohio's 88 counties to qualify for the ballot. By July 2023, organizers submitted over 222,000 signatures to the Ohio Secretary of State. After validation, the Ohio Ballot Board certified the measure as Issue 2 for the November 7, 2023 general election.

Issue 2 Victory and Implementation (2023-2024)

Ohio voters approved Issue 2 on November 7, 2023, with 57% voting in favor. The measure took effect on December 7, 2023, immediately legalizing adult possession and home cultivation. However, retail sales remained prohibited until the Division of Cannabis Control could establish licensing regulations. The Ohio General Assembly responded in December 2023 by passing House Bill 86, which modified several Issue 2 provisions. HB 86 reduced home cultivation limits from 12 plants per household to six, increased the excise tax from 10% to 15%, and gave municipalities broader authority to ban dispensaries through local ordinances. Governor Mike DeWine signed the bill on January 11, 2024, sparking legal challenges from reform advocates who argued the legislature had improperly altered a citizen-initiated statute. The Division of Cannabis Control opened adult-use dispensary applications in March 2024. Existing medical dispensaries received dual-use licenses allowing adult sales beginning June 1, 2024. By December 2024, Ohio had 130 active dispensaries serving both medical patients and adult consumers, generating over $400 million in combined annual sales.

Hemp Regulatory Confusion (2019-2026)

Parallel to cannabis reform, Ohio faced ongoing confusion over hemp-derived cannabinoids. The 2018 federal Farm Bill removed hemp (cannabis with less than 0.3% delta-9 THC) from Schedule I of the Controlled Substances Act, legalizing hemp cultivation and commerce. Ohio enacted conforming legislation in July 2019 under Ohio Rev. Code § 928, establishing a hemp cultivation licensing program through the Ohio Department of Agriculture. However, the law did not clearly address intoxicating hemp-derived cannabinoids such as delta-8 THC, delta-10 THC, and THCA. These compounds, synthesized from CBD or naturally occurring in hemp, proliferated in gas stations, smoke shops, and online retailers between 2020 and 2026. The Ohio Board of Pharmacy issued guidance in 2022 stating that delta-8 THC products required dispensary licensing, but enforcement remained inconsistent. By 2026, an estimated 2,000-3,000 Ohio retailers sold hemp-derived cannabinoid products in a legal gray area.

The 2026 Referendum Campaign Emerges

In January 2026, a coalition of hemp industry representatives, cannabis reform advocates, and business groups announced plans for a new referendum to address regulatory gaps. The proposed measure, titled the Ohio Cannabis and Hemp Regulation Act, sought to explicitly legalize and regulate hemp-derived cannabinoids, expand the list of qualifying medical conditions, and adjust the adult-use excise tax structure. Organizers formed a campaign committee and hired a professional signature-gathering firm in February 2026. The campaign needed approximately 133,000 valid signatures by July 2026 to qualify for the November 2026 ballot. Petition circulators were promised payment rates of $4 to $6 per valid signature, with bonuses for high-volume collectors. By April 2026, the campaign reported collecting over 50,000 signatures. However, in early May 2026, multiple petition circulators began reporting on social media and to local news outlets that they had not received promised payments for signatures submitted in March and April. Some circulators said they were owed $2,000 to $5,000 for weeks of work.

Key Players

Ohio Division of Cannabis Control

The Division of Cannabis Control, housed within the Ohio Department of Commerce, oversees all aspects of Ohio's medical and adult-use cannabis programs. Director James Canepa, appointed in 2023, manages licensing, compliance, and enforcement for cultivators, processors, testing laboratories, and dispensaries. The division operates under authority granted by Ohio Rev. Code § 3796 (medical) and Ohio Rev. Code § 3780 (adult-use). The division has not commented publicly on the 2026 referendum campaign's payment controversy, as citizen initiatives fall outside its regulatory jurisdiction until enacted.

Ohio Secretary of State

The Ohio Secretary of State's office, led by Secretary Frank LaRose as of 2026, administers the state's election system including ballot initiative certification. The office's Elections Division reviews petition signatures, validates voter registrations, and determines whether campaigns have met constitutional thresholds. For the 2026 cannabis referendum, the Secretary of State would conduct signature verification if the campaign submits petitions, but has no authority over campaign finance or payment disputes between organizers and circulators.

Ohio Cannabis and Hemp Regulation Act Campaign

The campaign committee behind the 2026 referendum has not publicly disclosed its full organizational structure or funding sources as of May 2026. Spokespeople identified in early press releases included hemp industry consultant Marcus Williams and cannabis policy attorney Jennifer Tao. The campaign hired Grassroots Signature Services, a Columbus-based petition firm, to manage signature collection. Neither the campaign committee nor Grassroots Signature Services responded to requests for comment from Marijuana Moment regarding the payment allegations.

Petition Circulators

At least a dozen petition circulators have publicly stated they were not paid as promised. Circulator David Chen told Cleveland television station WKYC in May 2026 that he collected approximately 800 signatures over four weeks in March and April but received no payment. Another circulator, Sarah Martinez, posted on Facebook that she was owed $3,200 for signatures submitted in early April. Ohio law does not require campaigns to pay petition circulators, but failure to honor payment agreements may constitute breach of contract under Ohio common law.

Coalition to Regulate Marijuana Like Alcohol

The Coalition to Regulate Marijuana Like Alcohol, which successfully led the 2023 Issue 2 campaign, has not formally endorsed or opposed the 2026 referendum. Coalition spokesperson Tom Haren stated in April 2026 that the organization was monitoring the new initiative but focusing resources on defending Issue 2 from legislative modifications. The coalition's 2023 campaign paid circulators through established petition firms and did not face similar payment controversies.

Ohio Cannabis Industry Operators

Multi-state operators with Ohio operations have largely remained neutral on the 2026 referendum. Cresco Labs operates three dispensaries in Ohio under the Sunnyside brand. Curaleaf holds four dispensary licenses. Ayr Wellness operates dispensaries in Columbus and Cincinnati. These companies have not publicly commented on the referendum or the payment controversy, likely due to concerns about appearing to fund citizen initiatives, which could trigger additional regulatory scrutiny.

Legal and Regulatory Framework

Ohio's cannabis and hemp regulations operate under a complex framework of state statutes, administrative rules, and constitutional provisions that govern both the substance of policy and the process of citizen-initiated reform. Ohio's medical marijuana program derives authority from Ohio Rev. Code § 3796, enacted by the legislature in 2016. The statute establishes a vertically integrated licensing system with separate licenses for cultivation (Level I facilities up to 25,000 square feet, Level II up to 3,000 square feet), processing, testing, and dispensing. The law limits medical marijuana to patients with qualifying conditions certified by physicians registered with the State Medical Board. Possession limits are set at a 90-day supply, defined by the State Board of Pharmacy as varying by product form and THC content. Adult-use legalization operates under Ohio Rev. Code § 3780, enacted by voter initiative in November 2023 as Issue 2. The statute legalized possession of up to 2.5 ounces of cannabis flower and 15 grams of concentrate for adults 21 and older. Home cultivation is permitted up to six plants per individual, with a household maximum of 12 plants reduced to six by subsequent legislative amendment. The statute imposed a 10% excise tax on retail sales, later increased to 15% by House Bill 86. Retail sales are restricted to licensed dispensaries, with licensing administered by the Division of Cannabis Control. Hemp regulation falls under Ohio Rev. Code § 928, which conforms Ohio law to the federal 2018 Farm Bill definition of hemp as cannabis containing no more than 0.3% delta-9 THC on a dry weight basis. The Ohio Department of Agriculture licenses hemp cultivators and processors. However, the statute does not explicitly address intoxicating hemp-derived cannabinoids such as delta-8 THC, which are synthesized from CBD through chemical processes. This gap has created regulatory ambiguity, with the Ohio Board of Pharmacy asserting jurisdiction over intoxicating cannabinoids while the Department of Agriculture maintains authority over hemp commerce. Ohio's citizen initiative process is governed by Article II, Section 1 of the Ohio Constitution. To place an initiated statute on the ballot, proponents must collect signatures equal to 3% of the total votes cast in the most recent gubernatorial election, with signatures from at least 44 of Ohio's 88 counties. For the 2026 election cycle, this threshold is approximately 133,000 valid signatures. Signatures must be submitted at least 125 days before the election. The Ohio Ballot Board, composed of the Secretary of State and four legislative appointees, reviews the petition and certifies it for the ballot if signature requirements are met. Ohio law does not regulate payment arrangements between initiative campaigns and petition circulators. Campaigns may use volunteer circulators or hire professional firms. Payment is typically structured as a per-signature rate, ranging from $3 to $8 depending on competition and difficulty. Failure to pay circulators as promised may constitute breach of contract under Ohio common law, but the Secretary of State and Attorney General have no enforcement authority over such disputes unless fraud or election law violations are alleged. Campaign finance for ballot initiatives is governed by Ohio Rev. Code § 3517, which requires campaign committees to register with the Secretary of State and file periodic financial disclosure reports. As of May 2026, the Ohio Cannabis and Hemp Regulation Act campaign had not filed disclosure reports showing payments to signature-gathering firms or individual circulators, though such reports may not be due until quarterly filing deadlines.

What Experts Say

Cannabis policy analysts, election law experts, and industry observers have offered varied perspectives on the referendum campaign's collapse and its implications for Ohio's cannabis landscape. According to Tom Haren, spokesperson for the Coalition to Regulate Marijuana Like Alcohol, professional signature-gathering campaigns require substantial upfront capital and rigorous financial management. Haren told Ohio Capital Journal in May 2026 that the coalition's successful 2023 campaign spent approximately $1.8 million on signature gathering, with payments processed weekly through established petition firms. Haren emphasized that campaigns must maintain cash reserves to cover payroll even when signature validation takes weeks. Douglas Berman, professor at Ohio State University Moritz College of Law and cannabis policy expert, noted that the 2026 referendum's payment controversy reflects broader challenges in grassroots organizing. Berman stated in a May 2026 blog post that citizen initiatives increasingly rely on professional signature-gathering firms rather than volunteer networks, raising the financial barriers to direct democracy. Berman suggested that Ohio's signature threshold, while constitutionally established, may be too high for underfunded campaigns to meet without significant institutional backing. According to Aaron Stuckey, owner of Buckeye Botanicals CBD in Columbus, the hemp industry desperately needs regulatory clarity. Stuckey told the Columbus Dispatch in April 2026 that his store stocks delta-8 THC products alongside CBD oils and topicals, but operates in constant uncertainty about whether state regulators might classify his inventory as requiring dispensary licensing. Stuckey said the 2026 referendum represented the hemp industry's best chance for clear rules, making the campaign's apparent collapse particularly frustrating. Cannabis industry analyst Vivien Azer of Cowen & Company stated in a May 2026 research note that Ohio's adult-use market is performing ahead of initial projections, with monthly sales averaging $35 million in the first quarter of 2026. Azer noted that regulatory stability matters more to institutional investors than incremental policy changes, suggesting that the failed referendum may have limited impact on Ohio's cannabis investment climate. Matt Schweich, deputy director of the Marijuana Policy Project, told Marijuana Moment in May 2026 that payment disputes between campaigns and circulators are relatively rare but can be devastating when they occur. Schweich said that word spreads quickly among professional circulators, making it difficult for campaigns with payment controversies to recruit new signature gatherers. Schweich suggested that the Ohio campaign would likely need to restart with new management and funding to have any chance of making the 2026 ballot.

Market and Business Implications

The referendum's failure has immediate consequences for Ohio's hemp retailers and longer-term implications for the state's cannabis market structure and investment climate. Ohio's hemp-derived cannabinoid market represents an estimated $50 million to $100 million in annual sales across 2,000-3,000 retail locations as of 2026. These retailers include dedicated CBD stores, vape shops, gas stations, and convenience stores. Products range from delta-8 THC vapes and gummies to THCA flower, which converts to delta-9 THC when heated. Without clear regulations, these retailers face ongoing risk of enforcement action by the Ohio Board of Pharmacy or local law enforcement. The referendum's collapse leaves this regulatory ambiguity unresolved for at least another election cycle. Ohio's next statewide election is in November 2027, meaning any new initiative would need to begin signature gathering in early 2027 to qualify. This extended uncertainty may drive some hemp retailers to exit the market or shift to non-intoxicating CBD products, reducing consumer access and market diversity. For licensed cannabis dispensaries, the referendum's failure maintains the current competitive landscape. Dispensaries hold exclusive authority to sell intoxicating cannabis products, protecting their market position from hemp retailers. However, the lack of clear hemp regulations also means dispensaries continue facing competition from unregulated delta-8 THC and THCA products sold at lower prices without excise taxes. Multi-state operators with Ohio investments are unlikely to alter strategic plans based on the referendum's failure. These companies focus on maximizing revenue from existing licenses rather than policy advocacy. Ohio's adult-use market generated approximately $400 million in sales in 2024 and is projected to reach $600 million to $700 million in 2026, making it a significant revenue source for operators like Cresco Labs, Curaleaf, and Ayr Wellness. The payment controversy may also affect future cannabis reform campaigns in Ohio. Professional petition circulators often work across multiple states and share information about campaigns that fail to pay. If the 2026 referendum campaign gains a reputation for non-payment, future Ohio cannabis initiatives may face higher per-signature costs or difficulty recruiting circulators, increasing the financial barriers to reform. From a capital markets perspective, Ohio's regulatory stability matters more than incremental policy changes. Institutional investors in cannabis companies prioritize states with established licensing frameworks and predictable tax structures. Ohio's adult-use program, now in its second year of retail sales, meets these criteria. The failed referendum does not materially change Ohio's investment profile for cannabis operators.

What's Next

The immediate future of the 2026 referendum remains uncertain, with multiple scenarios possible depending on whether organizers can resolve payment disputes and resume signature gathering. As of May 17, 2026, the campaign has until approximately July 10, 2026 to submit signatures for the November 2026 ballot, based on Ohio's 125-day pre-election deadline. This leaves roughly eight weeks for signature collection. Given that the campaign reportedly collected 50,000 signatures before the payment controversy, organizers would need approximately 83,000 additional valid signatures to meet the 133,000 threshold, accounting for a typical 15-20% invalid signature rate. Resuming signature gathering would require the campaign to resolve payment disputes with existing circulators and recruit new circulators willing to work despite the controversy. This likely requires securing additional funding and potentially replacing campaign management. Without swift action, the campaign will miss the 2026 ballot deadline. If the 2026 referendum fails to qualify, reform advocates could launch a new initiative for the November 2027 election. A 2027 campaign would need to begin signature gathering by early 2027 to meet deadlines. This timeline would allow organizers to rebuild credibility, secure funding, and potentially refine the referendum's policy provisions based on stakeholder feedback. The Ohio General Assembly could also address hemp regulation through legislation, preempting the need for a referendum. Several legislators have expressed interest in clarifying the legal status of delta-8 THC and other hemp-derived cannabinoids. However, legislative action faces competing pressures from hemp retailers seeking permissive regulations and licensed dispensaries preferring strict controls. As of May 2026, no hemp regulation bills have advanced beyond committee hearings. The Division of Cannabis Control may also take administrative action to clarify hemp regulations. The division could issue guidance or adopt rules defining which hemp-derived cannabinoids require dispensary licensing. However, such action would likely face legal challenges from hemp retailers arguing that the division lacks statutory authority over hemp, which falls under the Department of Agriculture's jurisdiction. For petition circulators who were not paid, legal recourse may be limited. Circulators could file small claims lawsuits against the campaign committee or signature-gathering firm for breach of contract. However, collecting judgments from underfunded campaigns is often difficult. Ohio law does not provide specific remedies for unpaid petition circulators beyond standard contract law.

Further Reading

• Ohio Revised Code § 3796 (Medical Marijuana Control Program) - https://codes.ohio.gov/ohio-revised-code/chapter-3796
• Ohio Revised Code § 3780 (Adult Use Cannabis) - https://codes.ohio.gov/ohio-revised-code/chapter-3780
• Ohio Revised Code § 928 (Hemp Cultivation) - https://codes.ohio.gov/ohio-revised-code/chapter-928
• Ohio Constitution Article II, Section 1 (Initiative and Referendum) - https://codes.ohio.gov/ohio-constitution/section-2.1
• Ohio Division of Cannabis Control Official Website - https://cannabis.ohio.gov
• Ohio Secretary of State Ballot Initiative Information - https://www.ohiosos.gov/elections/voters/ballot-issues/
• Coalition to Regulate Marijuana Like Alcohol - https://regulateohio.org
• Ohio State Medical Board Medical Marijuana Physician Registry - https://med.ohio.gov/medical-marijuana
• Ohio Department of Agriculture Hemp Program - https://agri.ohio.gov/divisions/plant-health/hemp
• Marijuana Moment Coverage of Ohio Cannabis Policy - https://www.marijuanamoment.net/tag/ohio/